Procurement and Perfusion-Decellularization of Porcine Vascularized Flaps in a Customized Perfusion Bioreactor
August 1st, 2022
2.6K views
The protocol describes the surgical procurement and subsequent decellularization of vascularized porcine flaps by the perfusion of sodium dodecyl sulfate detergent through the flap vasculature in a customized perfusion bioreactor.
Overview
This method describes the surgical procurement of vascularized porcine flaps and their subsequent perfusion decellularization. The technique can be broadly applied to other vascularized flaps as a potential tissue engineering solution in reconstructive surgery.
Key Study Components
Area of Science
- Tissue Engineering
- Reconstructive Surgery
- Decellularization Techniques
Background
- Vascularized porcine flaps are used in reconstructive surgery.
- Decellularization is a method to remove cellular components from tissues.
- This technique allows for the regeneration of tissues.
- Custom bioreactor setups can facilitate the perfusion process.
Purpose of Study
- To describe a method for decellularizing vascularized porcine flaps.
- To enhance the versatility of tissue engineering approaches.
- To provide a simple assembly method for bioreactors.
Methods Used
- Surgical procurement of vascularized porcine flaps.
- Perfusion of sodium dodecyl sulfate detergent through flap vasculature.
- Use of a customized perfusion bioreactor.
- Assembly of inflow and outflow tubing for perfusate delivery.
Main Results
- The method successfully decellularizes vascularized porcine flaps.
- Demonstrated versatility across various flap types.
- Provided a straightforward bioreactor setup for researchers.
- Potential applications in tissue engineering for reconstructive surgery.
Conclusions
- This technique offers a reliable method for tissue decellularization.
- It can be adapted for different types of vascularized flaps.
- The approach supports future research in tissue engineering.
Frequently Asked Questions
What is the main advantage of this technique?
The main advantage is its versatility to achieve perfusion decellularization across various vascularized porcine flaps.
How does the perfusion process work?
Perfusion involves the delivery of sodium dodecyl sulfate detergent through the flap vasculature to remove cellular components.
Can this method be applied to other types of flaps?
Yes, the technique can be broadly applied to other vascularized flaps in tissue engineering.
What materials are needed for the bioreactor setup?
You will need LS16 platinum-coated silicone tubing, a yellow 3-stop pump tubing, and a sterile serological pipette.
What is the purpose of decellularization?
Decellularization removes cellular components to create a scaffold for tissue regeneration.
Is this method suitable for clinical applications?
The method is primarily for research purposes but has potential clinical applications in reconstructive surgery.
How can I access the full transcript of the study?
You can view the full transcript and gain access to thousands of scientific videos through JoVE.
Executive Industry Relevance
Perfusion-decellularization of porcine vascularized flaps in a customized bioreactor enables the generation of acellular scaffolds with preserved extracellular matrix and vascular microarchitecture. This capability addresses a critical bottleneck in tissue engineering for reconstructive applications, supporting translational research and future recellularization studies. The method enhances predictive confidence in scaffold quality and supports risk-adjusted advancement in regenerative medicine pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of tissue engineering hypotheses using large animal models.
- Supports biological de-risking by preserving native ECM and vascular structures.
- Facilitates functional validation of decellularization protocols for translational use.
Screening & Assay Development
- Provides standardized acellular scaffolds for downstream recellularization and functional assays.
- Ensures reproducibility and quantitative assessment of decellularization efficiency.
- Prepares validated biological matrices for scalable tissue engineering workflows.
Translational & Preclinical Research
- Aligns scaffold properties with disease-relevant reconstructive models.
- Enables continuity from scaffold generation to preclinical recellularization studies.
- Supports risk-adjusted decisions for advancing engineered tissues toward clinical translation.
Pipeline & Workflow Integration
This method integrates into the regenerative medicine continuum from scaffold generation to preclinical recellularization and functional validation.
- Discovery Biology: Supports hypothesis testing on ECM preservation and vascular integrity post-decellularization.
- Screening: Delivers reproducible, acellular matrices for comparative recellularization studies.
- Analytics: Enables quantitative DNA content measurement and histological assessment of scaffold quality.
- Translational Research: Bridges scaffold production with preclinical evaluation in large animal models.
- Enterprise Reuse: Establishes a reusable bioreactor platform adaptable to various tissue types and research needs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in scaffold suitability for tissue engineering.
- Operational Value: Standardizes decellularization and bioreactor workflows for reproducibility and scalability.
- Strategic Value: Improves go/no-go decisions for advancing engineered tissues in the R&D pipeline.
- Portfolio Impact: Enables risk-adjusted prioritization of tissue engineering programs for reconstructive applications.
Implementation Considerations
- Requires surgical expertise for vascularized flap procurement and cannulation.
- Needs access to sterile bioreactor systems and perfusion instrumentation.
- Demands cross-team standardization of decellularization protocols and quality metrics.
- Adaptable to multiple porcine flap types but dependent on careful pedicle preservation.
- Limitations include the need for rigorous histological and DNA quantification to confirm decellularization.
Biopharma FAQs
Why does null hypothesis testing matter for decellularization protocol validation?
Null hypothesis testing ensures that observed reductions in DNA content and loss of nuclei in decellularized flaps are statistically significant, supporting robust target validation for scaffold quality.
How does independent variable isolation fit in perfusion bioreactor optimization?
Isolating variables such as perfusion rate, detergent concentration, and flap type allows systematic optimization of decellularization conditions, improving reproducibility and scalability in tissue engineering workflows.
What do quantitative DNA measurements enable in scaffold assessment?
Quantitative DNA content analysis provides objective metrics for confirming effective decellularization, enabling comparison across flaps and supporting go/no-go decisions for downstream recellularization.
Why are replication requirements critical for cross-functional tissue engineering teams?
Replication of decellularization outcomes across multiple flaps and experiments ensures reproducibility, facilitating collaboration between procurement, bioreactor, and analytical teams in translational research.
What statistical analysis capabilities are required before scaffold implementation?
Statistical analysis of DNA reduction and histological results is essential to validate scaffold acellularity and consistency, supporting risk-adjusted advancement in regenerative medicine pipelines.
Chapters in this video
0:05
Introduction
0:57
Perfusion Bioreactor Fabrication
1:29
Procurement of Porcine Flaps
5:51
Setup of the Decellularization System
7:39
Decellularization of Porcine Flaps and Evaluation of Decellularization
9:06
Results: Perfusion-Decellularization of Porcine Vascularized Flaps
10:16
Conclusion
